"Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with Curaderm BEC5"

A recent published randomised clinical trial has shown that Curaderm BEC5 eliminates over 80% of Actinic Keratoses with only 3 days of treatment.  This study also showed that 1 tube of Curaderm BEC5 can clear over 30 Actinic Keratotic lesions. See link: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=29980